NEGEV CAPITAL
Negev Capital is a psychedelic medical intervention investment fund with assets of USD$20+ million. We invest in drug discovery, with a focus on preclinical and/or Phase 1 stages of development. We aim to support those early stage companies in need of capital that promote the thoughtful, responsible, medical use of psychedelic medication for psychiatric disorders, and who have excellent management and science teams, and solid IP.
NEGEV CAPITAL
Industry:
Biotechnology Pharmaceutical
Founded:
2021-01-07
Status:
Active
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API LetsEncrypt Content Delivery Network Microsoft Exchange Online Office 365 Mail Microsoft Azure DNS
Similar Organizations
Current Employees Featured
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2022-02-10 | Mindstate Design Labs | Negev Capital investment in Seed Round - Mindstate Design Labs | 11.5 M USD |
| 2021-09-27 | Delix Therapeutics | Negev Capital investment in Series A - Delix Therapeutics | 70 M USD |
| 2021-09-21 | MycroDose Therapeutics | Negev Capital investment in Seed Round - MycroDose Therapeutics | N/A |
| 2021-08-15 | Beckley Psytech | Negev Capital investment in Series B - Beckley Psytech | 58 M GBP |
| 2021-06-29 | NanoPsy | Negev Capital investment in Seed Round - NanoPsy | 500 K CAD |